pirinixic acid has been researched along with Non-alcoholic Fatty Liver Disease in 3 studies
pirinixic acid: structure
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PPAR-alpha activation reduced BM and treated insulin resistance (IR) and NAFLD by increasing the number of mitochondria and reducing hepatic gluconeogenesis and de novo lipogenesis protein and gene expressions in a murine obesity model." | 1.46 | Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice. ( Barreto, AB; Graus-Nunes, F; Mandarim-de-Lacerda, CA; Rachid, TL; Souza-Mello, V; Veiga, FMS, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veiga, FMS | 1 |
| Graus-Nunes, F | 1 |
| Rachid, TL | 1 |
| Barreto, AB | 1 |
| Mandarim-de-Lacerda, CA | 1 |
| Souza-Mello, V | 1 |
| Larter, CZ | 1 |
| Yeh, MM | 1 |
| Van Rooyen, DM | 1 |
| Brooling, J | 1 |
| Ghatora, K | 1 |
| Farrell, GC | 1 |
| Walter, R | 1 |
| Wanninger, J | 1 |
| Bauer, S | 1 |
| Eisinger, K | 1 |
| Neumeier, M | 1 |
| Weiss, TS | 1 |
| Amann, T | 1 |
| Hellerbrand, C | 1 |
| Schäffler, A | 1 |
| Schölmerich, J | 1 |
| Buechler, C | 1 |
3 other studies available for pirinixic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dietary Fats; fas Receptor; Ge | 2017 |
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Topics: Adipose Tissue; Animals; Blotting, Western; Chemokine CCL2; Diabetes Mellitus; Disease Models, Anima | 2012 |
Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.
Topics: Adiponectin; Anticholesteremic Agents; Connective Tissue Growth Factor; Down-Regulation; Fatty Liver | 2011 |